Does topical anaesthetic gel reduce pain/discomfort during intrauterine device (IUD)/intrauterine system (IUS) insertion? A randomised, placebo-controlled, double-blind trial

Does topical anaesthetic gel (Instillagel®) reduce pain discomfort during insertion of intrauterine contraception? A randomised, placebo-controlled, double-blind trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN83819888

Enrollment

200

Registered

2008-08-21

Start date

2008-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unintended pregnancy and abortion Pregnancy and Childbirth Contraceptive management

Interventions

2% lignocaine gel (Instillagel®

topical) or an inert equivalent of it will be provided by the manufacturer of Instillagel®. This will be coded and the code only released at the end of the trial. Neither the woman, or the clinician (

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women choosing an IUD/IUS, for whom this is an appropriate choice of contraception 2. Between the ages of 16 and 45

Exclusion criteria

Exclusion criteria: Women choosing an IUD/IUS, for whom this is not an appropriate choice of contraception

Design outcomes

Primary

Measure	Time frame
Pain scores at the end of the insertion procedure. Pain scores will be assessed visually using a numerical rating scale of 1-10.	—

Secondary

Measure	Time frame
Pain scores relating to the use of the Allis forceps prior to IUD/IUS insertion. Pain scores will be assessed visually using a numerical rating scale of 1-10.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026